// App-Quantinova.ai

: Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study

Researchers

Presenter

  • Jrgen Vestbo

Principal Investigators

  • Helen K Reddel

  • Alvar Agust

  • Elisabeth H Bel

  • Christer Janson

  • Barry Make

  • David Price

  • Rod Hughes

  • Eleni Rapsomaniki

  • Niklas Karlsson

  • Javier Nuevo

  • Stephen I Rennard

  • Alex De Giorgio-Miller

  • Marianna Alacqua

  • Maria Gerhardsson De Verdier

Medical Centers

  • University of Manchester, Manchester, United Kingdom

  • Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.

  • Respiratory Institute, Hospital Clinic, University of Barcelona, IDIBAPS, CIBER, Barcelona, Spain,

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

  • National Jewish Health and Research and University of Colorado, Denver, United States of America

  • Observational and Pragmatic Research Institute, Singapore and Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom

  • AstraZeneca, Gothenburg, Sweden

  • AstraZeneca, Madrid, Spain

  • Early Clinical Development, IMED Biotech Unit, AstraZeneca UK Ltd, Melbourn, United Kingdom,

Locations

  • United Kingdom

  • Australia

  • Spain

  • Netherlands

  • Sweden

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A